The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with <it>HER2 </it>over-expression that are at an increased risk of recurrence

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with <it>HER2 </it>over-expression that are at an increased risk of recurrence

<p>Abstract</p> <p>Background</p> <p>Over-expression of <it>HER2 </it>in a subset of breast cancers (<it>HER2</it>+) is associated with high histological grade and aggressive clinical course. Despite these distinctive features, the differences in...

Full description

Bibliographic Details
Main Authors: Tubbs Raymond, Yoder Brian J, Budd G, Dim Daniel, Khoury Thaer, Kulkarni Swati A, Vardarajan Ramya, Janarthanan Bagi R, Hicks David G, Schreeder Marshall T, Estopinal Noel C, Beck Rodney A, Wang Yanling, Ring Brian Z, Seitz Robert S, Ross Douglas T
Format: Article
Language:English
Published: BMC 2010-03-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/108

Internet

http://www.biomedcentral.com/1471-2407/10/108

Similar Items